Riskpilot← Back to searchSign inGet full accessKirurghuset i Västerås AB
ABActiveOrg 5592932742Kopparbergsvägen 14 Vån 3Hospital activities · NACE 8610Est. 202010-19 employees
Revenue 2024
SEK 8,9M
+86% vs 2023
EBITDA margin
-47.9%
-72% vs 2023
Equity ratio
4.8%
Financial strength
Net profit 2024
SEK -44K
+42% vs 2023
| Revenue | SEK 8,9M | +86% |
| EBITDA | SEK -4,2M | -72% |
| Net profit | SEK -44K | +42% |
| Total assets | SEK 11,9M | +30% |
| Equity | SEK 567K | -7% |
| Employees | — | — |
Legal name
Kirurghuset i Västerås AB
Org number
5592932742
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
22 december 2020
Share capital
SEK 100 000
Employees
10-19
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Sjukvård med inriktning på kirurgisk och endoskopisk specialité med mottagnings- och operationsverksamhet och därmed förenlig verksamhet samt utvecklingsarbete och utbildning inom kirurgi och endoskopi.
Address
Kopparbergsvägen 14 Vån 3
Email
per.videhult@kirurghuset.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 769 | 4 770 | 8 868 |
| Staff expenses | — | −2 | −2 556 | −7 120 |
| EBITDA | −7 | 748 | −2 466 | −4 249 |
| Depreciation & amort. | −0 | — | −611 | −1 282 |
| EBIT | −7 | 748 | −3 077 | −5 532 |
| Net financials | — | 0 | 0 | −12 |
| Profit before tax | −7 | 748 | −77 | −44 |
| Tax | −0 | −153 | — | — |
| Net profit | −7 | 595 | −77 | −44 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 100 | 1 062 | 9 180 | 11 895 |
| Equity | 93 | 688 | 612 | 567 |
| Long-term debt | 0 | — | 7 760 | 8 260 |
| Short-term debt | 7 | 374 | 808 | 3 067 |
| Total debt | 7 | 374 | 8 569 | 11 328 |
EBITDA margin
-47.9%
This company
15.8%
Market median
-403% vs market
20212024
Equity ratio
4.8%
This company
38.2%
Market median
-87% vs market
20212024
Return on equity
-7.8%
This company
18.4%
Market median
-142% vs market
20212024
Net profit margin
-0.5%
This company
8.1%
Market median
-106% vs market
20212024
Asset turnover
0.75×
This company
1.12×
Market median
-33% vs market
20212024
Debt / equity
19.97×
This company
0.62×
Market median
-3121% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SV Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2021 | |
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Former (2) | ||
| Deputy Board Member | 2021 – 2022 | |
| Chairman | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PerSim AB
Kirurghuset i Västerås AB Board members of Kirurghuset i Västerås AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Simin Videhult | Deputy Chief Executive Officer | 0 companies |
| Emil Sam Videhult | Deputy Board Member | 0 companies |
| Linus Armin Videhult | Deputy Board Member | 0 companies |
| Sven Samuel Flykt | Deputy Board Member | 0 companies |
| Per Georg Videhult | Chairman | 0 companies |
| Karin Maria Flykt | Chairman | 0 companies |